← back to search

Shu Mei Teo

Orygen Youth Health ·
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Gut microbiota and health, Health disparities and outcomes, Genetic Associations and Epidemiology, and Pediatric health and respiratory diseases.
h-index
22
citations
3,126
works
82
NIH funding
primary concept
email

Recent publications

Integration of polygenic and gut metagenomic risk prediction for common diseases
Nature Aging 2024cited by 23position: middledoi
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Cell Metabolism 2022cited by 86position: middledoi
The gut microbiome is a significant risk factor for future chronic lung disease
Journal of Allergy and Clinical Immunology 2022cited by 62position: middledoi
Developmental patterns in the nasopharyngeal microbiome during infancy are associated with asthma risk
Journal of Allergy and Clinical Immunology 2020cited by 95position: middledoi
Neonatal genetics of gene expression reveal potential origins of autoimmune and allergic disease risk
Nature Communications 2020cited by 43position: middledoi
Luminal microbiota related to Crohn’s disease recurrence after surgery
Gut Microbes 2020cited by 40position: lastdoi
The early-life nasopharyngeal microbiome interacts with allergic and non-allergic mechanisms of childhood wheeze
UWA Profiles and Research Repository (University of Western Australia) 2019cited by 3position: middle
Airway Microbiota Dynamics Uncover a Critical Window for Interplay of Pathogenic Bacteria and Allergy in Childhood Respiratory Disease
Cell Host & Microbe 2018cited by 203position: firstdoi
Trajectories of childhood immune development and respiratory health relevant to asthma and allergy
eLife 2018cited by 27position: middledoi
The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma Development
Cell Host & Microbe 2015cited by 962position: firstdoi
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer
Neuro-Oncology 2015cited by 96position: middledoi
Deep Whole-Genome Sequencing of 100 Southeast Asian Malays
The American Journal of Human Genetics 2013cited by 198position: middledoi
Statistical challenges associated with detecting copy number variations with next-generation sequencing
Bioinformatics 2012cited by 244position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Inouye · Baker Heart and Diabetes Institute10 papers (2015–2024)Kathryn E. Holt · London School of Hygiene & Tropical Medicine6 papers (2015–2020)Patrick G. Holt · The University of Western Australia6 papers (2015–2020)Peter D. Sly · Barwon Health5 papers (2015–2020) · 5 papers (2018–2022)James E. Gern · University of Wisconsin–Madison5 papers (2015–2020)Robert F. Lemanske · University of Wisconsin–Madison4 papers (2018–2020)Rob Knight · University of California San Diego3 papers (2022–2024)Sebastian L. Johnston · Imperial College Healthcare NHS Trust3 papers (2015–2018)Merci Kusel · The University of Western Australia3 papers (2015–2018)Aki S. Havulinna · University of Helsinki3 papers (2022–2024)Qiyun Zhu · Central South University3 papers (2022–2024)Veikko Salomaa · Varsinais-Suomen Sairaanhoitopiiri3 papers (2022–2024)Karin Verspoor · MIT University3 papers (2022–2024)Jon G. Sanders · Cornell University3 papers (2022–2024)Guillaume Méric · Baker Heart and Diabetes Institute3 papers (2022–2024)Pekka Jousilahti · University of Helsinki3 papers (2022–2024)Teemu Niiranen · University of Turku3 papers (2022–2024)Leo Lahti · University of Helsinki3 papers (2022–2024)Yang Liu · Baker Heart and Diabetes Institute3 papers (2022–2024)